Cargando…

微环境中巨噬细胞、肿瘤新生血管及PD-L1的表达及其与非小细胞肺癌患者预后的关系

BACKGROUND AND OBJECTIVE: Tumor microenvironment is a complex and dynamic community, which plays a crucial role in tumor progression via the co-evolution of cancer cells and tumor stroma. Among them, tumor-associated macrophages (TAMs) and tumor neo-vessels are two key components in the tumor microe...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583870/
https://www.ncbi.nlm.nih.gov/pubmed/33070512
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.103.15
_version_ 1783599476401766400
collection PubMed
description BACKGROUND AND OBJECTIVE: Tumor microenvironment is a complex and dynamic community, which plays a crucial role in tumor progression via the co-evolution of cancer cells and tumor stroma. Among them, tumor-associated macrophages (TAMs) and tumor neo-vessels are two key components in the tumor microenvironment during cancer invasion. In addition, programmed cell death ligand 1/programmed cell death ligand 1 (PD-1/PD-L1) also plays an important role in tumorigenesis and development, and the clinical strategies to block PD-1/PD-L1 pathway could have great benefits for cancer patients. This study was aimed at analyzing the quantitative expression and prognostic significance of TAMs, tumor neo-vessels and PD-L1 in tumor microenvironment and exploring the relations between the expression of above components with the patients' prognosis of non-small cell lung cancer (NSCLC). METHODS: Clinico-pathological data and surgical specimens of 92 patients with NSCLC were collected, and immunohistochemistry was used to stain the expression of TAMs, tumor neo-vessels and PD-L1 on tumor tissue and peri-tumor tissues. The inverted microscopy was used to take pictures and Image-pro Plus 6.0 software was used for quantitative analysis. The clinicopathological characteristics and overall survival (OS) were analyzed. RESULTS: The median OS of 92 NSCLC cases was 22.5 month. The expression of TAMs, tumor neo-vessels and PD-L1 in tumor tissue and peri-tumor tissues were not statistically significant (P > 0.05). According to the cutoff of above key three components in tumor microenvironment, all the cases could be classified into high, middle and low expression groups. The survival analysis demonstrated that the OS in high expression group of TAMs (P=0.016) and PD-L1 (P=0.002) was shorter than the other two groups, respectively, with statistical significance. The OS in high tumor neo vessels group was shorter than the other two groups. However, there was no statistical significance between these three group (P=0.626). Combined with above the three components, all the cases could be classified into low, middle and high density groups. The survival analysis demonstrated that the median OS of combined high density group was shorter than the other two groups (P=0.001). Multivariate analysis by Cox regression indicated that pathological type, TAMs and PD-L1 expression were the independent prognostic factors. CONCLUSION: The key components of TAMs and PD-L1 in tumor microenvironment are closely related to the prognosis of NSCLC patients.
format Online
Article
Text
id pubmed-7583870
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-75838702020-11-02 微环境中巨噬细胞、肿瘤新生血管及PD-L1的表达及其与非小细胞肺癌患者预后的关系 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: Tumor microenvironment is a complex and dynamic community, which plays a crucial role in tumor progression via the co-evolution of cancer cells and tumor stroma. Among them, tumor-associated macrophages (TAMs) and tumor neo-vessels are two key components in the tumor microenvironment during cancer invasion. In addition, programmed cell death ligand 1/programmed cell death ligand 1 (PD-1/PD-L1) also plays an important role in tumorigenesis and development, and the clinical strategies to block PD-1/PD-L1 pathway could have great benefits for cancer patients. This study was aimed at analyzing the quantitative expression and prognostic significance of TAMs, tumor neo-vessels and PD-L1 in tumor microenvironment and exploring the relations between the expression of above components with the patients' prognosis of non-small cell lung cancer (NSCLC). METHODS: Clinico-pathological data and surgical specimens of 92 patients with NSCLC were collected, and immunohistochemistry was used to stain the expression of TAMs, tumor neo-vessels and PD-L1 on tumor tissue and peri-tumor tissues. The inverted microscopy was used to take pictures and Image-pro Plus 6.0 software was used for quantitative analysis. The clinicopathological characteristics and overall survival (OS) were analyzed. RESULTS: The median OS of 92 NSCLC cases was 22.5 month. The expression of TAMs, tumor neo-vessels and PD-L1 in tumor tissue and peri-tumor tissues were not statistically significant (P > 0.05). According to the cutoff of above key three components in tumor microenvironment, all the cases could be classified into high, middle and low expression groups. The survival analysis demonstrated that the OS in high expression group of TAMs (P=0.016) and PD-L1 (P=0.002) was shorter than the other two groups, respectively, with statistical significance. The OS in high tumor neo vessels group was shorter than the other two groups. However, there was no statistical significance between these three group (P=0.626). Combined with above the three components, all the cases could be classified into low, middle and high density groups. The survival analysis demonstrated that the median OS of combined high density group was shorter than the other two groups (P=0.001). Multivariate analysis by Cox regression indicated that pathological type, TAMs and PD-L1 expression were the independent prognostic factors. CONCLUSION: The key components of TAMs and PD-L1 in tumor microenvironment are closely related to the prognosis of NSCLC patients. 中国肺癌杂志编辑部 2020-10-20 /pmc/articles/PMC7583870/ /pubmed/33070512 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.103.15 Text en 版权所有©《中国肺癌杂志》编辑部2020 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 临床研究
微环境中巨噬细胞、肿瘤新生血管及PD-L1的表达及其与非小细胞肺癌患者预后的关系
title 微环境中巨噬细胞、肿瘤新生血管及PD-L1的表达及其与非小细胞肺癌患者预后的关系
title_full 微环境中巨噬细胞、肿瘤新生血管及PD-L1的表达及其与非小细胞肺癌患者预后的关系
title_fullStr 微环境中巨噬细胞、肿瘤新生血管及PD-L1的表达及其与非小细胞肺癌患者预后的关系
title_full_unstemmed 微环境中巨噬细胞、肿瘤新生血管及PD-L1的表达及其与非小细胞肺癌患者预后的关系
title_short 微环境中巨噬细胞、肿瘤新生血管及PD-L1的表达及其与非小细胞肺癌患者预后的关系
title_sort 微环境中巨噬细胞、肿瘤新生血管及pd-l1的表达及其与非小细胞肺癌患者预后的关系
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583870/
https://www.ncbi.nlm.nih.gov/pubmed/33070512
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.103.15
work_keys_str_mv AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì
AT wēihuánjìngzhōngjùshìxìbāozhǒngliúxīnshēngxuèguǎnjípdl1debiǎodájíqíyǔfēixiǎoxìbāofèiáihuànzhěyùhòudeguānxì